VTRS · Viatris Inc
United States · RS rating 92 · As of 2026-11-03
| Price | 18.92 USD |
|---|---|
| 1-day change | +1.3% |
| RS rating (overall / 1M / 3M / 12M) | 92 / 77 / 79 / 92 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 50 / 79 / 50 |
| Industry group (rank) | Medical-Generic Drugs (136) |
| EPS growth Q/Q | -172.7% |
| Sales growth Q/Q | -1.5% |
| Distance from 52-week high | +1.5% |
| Market cap (USD) | $17.2B |